絞り込み

16548

広告

Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial.

著者 Cosenso-Martin LN , Giollo-Júnior LT , Fernandes LAB , Cesarino CB , Nakazone MA , de Nassau Machado M , Yugar-Toledo JC , Vilela-Martin JF
Acta Diabetol.2018 Aug 09 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (63view , 0users)

Full Text Sources

Medical

Miscellaneous

Several trials have reported that dipeptidyl peptidase-4 (DPP-4) inhibitors, used to treat type 2 diabetes (T2DM), improve endothelial function. The current study investigated the effects of vildagliptin, a DPP-4 inhibitor, compared to glibenclamide on endothelial function, arterial stiffness, and blood pressure in patients with T2DM and hypertension.
PMID: 30094725 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード